Silexion Therapeutics Corp (SLXN)

NASDAQ: SLXN · Real-Time Price · USD

0.3800

+0.0400 (11.76%)

At close: Sep 17, 2026, 4:00 PM EDT

0.3764

-0.0036 (-0.95%)

After-hours: Sep 17, 2026, 7:59 PM EDT

Silexion Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2013	FY 2012
Period Ending	Sep '26 Sep 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Market Capitalization	2	6	3	42	-	-
Market Cap Growth	1.00%	86.31%	-92.33%	-	-	-
Enterprise Value	1	-1	6	41	-	-
Last Close Price	0.38	19.20	301.50	14647.49	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2013	FY 2012
Period Ending	Sep '26 Sep 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
PB Ratio	48.02	2.31	-0.81	13.99	-	-
P/TBV Ratio	48.02	2.31	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2013	FY 2012
Period Ending	Sep '26 Sep 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Debt / Equity Ratio	32.05	0.78	-1.13	0.06	-	-
Net Debt / Equity Ratio	-18.61	-1.52	-0.83	-1.47	-1.13	-0.98
Net Debt / EBITDA Ratio	0.06	0.34	-0.26	0.95	0.58	1.68
Net Debt / FCF Ratio	0.07	0.37	-0.39	0.97	0.99	1.75
Quick Ratio	0.56	2.17	0.34	2.09	3.64	10.47
Current Ratio	0.94	2.41	0.64	2.27	3.85	10.64
Return on Equity (ROE)	-	-	-	-	-116.66%	-
Return on Assets (ROA)	-	-144.28%	-193.54%	-	-62.13%	-
Return on Capital Employed (ROCE)	-5232.20%	-261.00%	1904.70%	-153.00%	-195.10%	-58.60%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2013	FY 2012
Period Ending	Sep '26 Sep 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Earnings Yield	-660.61%	-198.43%	-510.32%	-11.77%	-	-
FCF Yield	-588.39%	-180.37%	-261.26%	-10.82%	-	-

SEC Filings: 10-K · 10-Q